Navigation Links
Could Weight Loss Be Early Sign of Alzheimer's?

By Amanda Gardner
HealthDay Reporter

MONDAY, Nov. 21 (HealthDay News) -- People with early evidence of Alzheimer's disease are more likely to be underweight than people who don't have this type of dementia, a new study suggests.

"Weight loss may be a manifestation of the disease process progressing," said Eric Vidoni, lead author of a study appearing in the Nov. 22 issue of Neurology. "This may be further evidence for body-wide or systemic changes associated with Alzheimer's disease ... and it certainly supports the idea that Alzheimer's disease-related changes could be silently occurring, i.e., a 'preclinical' phase."

The findings may hold implications for diagnosis, prevention or treatment, but these are likely to be years or even decades away.

"A long history of declining weight or BMI (body mass index, a ratio of weight to height) could aid the diagnostic process," said Vidoni, who is assistant director of the University of Kansas Alzheimer's Disease Center in Kansas CityIs.

At this point, though, it's too early "to make body composition part of the diagnostic toolbox," he added.

"If weight loss is part of the disease process, this could suggest, along with the many papers linking metabolic dysfunction with AD, that preventing such dysfunction could reduce the progression of AD," said Ian Murray, an assistant professor of neuroscience and experimental therapeutics at the Texas A&M Health Science Center College of Medicine. "Of course this is, at present, speculative."

Previous studies have found that people who are overweight in middle age or earlier have a higher risk of developing Alzheimer's. And those who are overweight in their later years actually may have a lower risk of Alzheimer's, something known as the "obesity paradox."

Vidoni and his partners looked at PET (positron emission tomography) imaging of the brain and analyzed cerebrospinal fluid for markers of Alzheimer's disease in 506 people. Participants represented a range of cognitive function, some with no memory problems, some with mild cognitive impairment and some with Alzheimer's.

People with evidence of Alzheimer's -- either in brain scans or protein levels in the cerebrospinal fluid -- were more likely to have a lower BMI than those who did not show early evidence of the disease.

And the markers of brain changes for Alzheimer's were most evident in people with normal memory functioning or mild cognitive impairment, although it's not clear yet why this is.

There are a number of theories -- but only theories at this point -- to explain the findings.

One is that the Alzheimer's disease process is affecting the hippocampus, that part of the brain involved in metabolism and appetite.

Or inflammatory processes may be driving both the decreased BMI and the cognitive changes.

More Information

The Alzheimer's Association has more on has more on this condition.

SOURCES: Eric Vidoni, Ph.D., assistant director, University of Kansas Alzheimer's Disease Center, Kansas City, Kan.; Ian Murray, Ph.D., assistant professor, neuroscience and experimental therapeutics, Texas A&M Health Science Center College of Medicine, College Station; Nov. 22, 2011, Neurology

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Improved method of electrical stimulation could help treat damaged nerves
2. New smart material could help tap medical potential of tissue-penetrating light
3. Could Womens Use of the Pill Raise Mens Prostate Cancer Risk?
4. Burns app could save lives at the touch of a button
5. Regular Teeth Cleanings Could Cut Heart Attack Risk: Study
6. Greenhouse Gas Emissions Could Fall as Population Ages
7. Scientists discover how to design drugs that could target particular nerve cells
8. Computer Pathologist Could Help Assess Breast Cancer Survival
9. Early trial suggests rectal microbicide is safe, could significantly reduce HIV transmission
10. Birth cohort screening for hepatitis C is cost effective, could save thousands of lives each year
11. Wayne State therapeutic marijuana use study could impact state policies, guide treatment
Post Your Comments:
Related Image:
Could Weight Loss Be Early Sign of Alzheimer's? 
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: